CTLA4 and neoplasm: They can also upregulate immunosuppressive molecules, such as PD-1(programmed cell death protein 1) and CTLA-4 (cytotoxic T-lymphocyte-associated protein 4), further inhibiting anti-tumor immune responses by suppressing the antigen-presenting capability of antigen-presenting cells (such as macrophages).